The Glaucoma and Retinopathy Screening Study
Sponsor: Massachusetts Eye and Ear Infirmary • ClinicalTrials.gov ID: NCT06882356
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Interventions
-
AI-based glaucoma screening
(Device)
AI analysis of fundus photographs to detect signs of glaucoma, added to AI-based diabetic eye disease screening
-
IOP measurement
(Device)
Intraocular pressure measurement by Icare tonometer
-
Virtual Reality Visual Field Testing
(Device)
Virtual Reality Visual Field Testing by the Olleyes device for participants suspected of having glaucoma
Eligibility criteria
Conditions
Locations
- Massachusetts General Hospital Internal Medicine Associates — Boston, Massachusetts, United States
- Brigham and Women's Primary Care Associates of Longwood — Boston, Massachusetts, United States
- Massachusetts General Hospital Broadway Primary Care-Revere — Boston, Massachusetts, United States
- MGH Chelsea HealthCare Center — Chelsea, Massachusetts, United States
- NSPG Lynn — Lynn, Massachusetts, United States
- NSPG Salem — Salem, Massachusetts, United States
- NSPG Saugus — Saugus, Massachusetts, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record